TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24633725

Group type: EXPERIMENTAL
Intervention: Health literacy (listening)
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Health literacy (reading)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Pap testing adherence
Number of subjects: 527
Study: 22041253

Group type: EXPERIMENTAL
Intervention: ABO (Dysport) at 2.5:1.0 U
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ABO (Dysport) at 2.0:1.0 U
Number of subjects: 59

Group type: COMPARATOR
Intervention: ONA (Botox) at 2.5:1.0 U
Number of subjects: 59

Group type: COMPARATOR
Intervention: ONA (Botox) at 2.0:1.0 U
Number of subjects: 59
Study: 20466698

Group type: EXPERIMENTAL
Intervention: Antibiotic impregnated catheters (Bactiseal)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Conventional catheters with systemic antibiotics
Number of subjects: 184
Study: 18361280

Group type: EXPERIMENTAL
Intervention: Parental counseling and medical care for selective and restrictive children without growth retardation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family approaches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin and calcium supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prepubertal anorexic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Very-early-onset anorexia nervosa
Number of subjects: 0
Study: 16061893

Group type: EXPERIMENTAL
Intervention: Rapid magnetic resonance imaging (rMRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal distribution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gamma distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lognormal distribution
Number of subjects: 0
Study: 12374237

Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation
Number of subjects: 230

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 230
Study: 10404864

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7750585

Group type: EXPERIMENTAL
Intervention: Depot leuprolide acetate (3.75 mg JM depot LA given every month and daily placebo tablets)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Danazol (800 mg oral danazol daily with a monthly placebo injection)
Number of subjects: 12
Study: 2111189

Group type: EXPERIMENTAL
Intervention: (R)-tocainide
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: (S)-tocainide
Number of subjects: 6
Study: 7270842

Group type: EXPERIMENTAL
Intervention: 50 micrograms fentanyl/kg body weight
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.5-1.0% halothane
Number of subjects: 16
Study: 31480900

Group type: EXPERIMENTAL
Intervention: Headache specialists with migraine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General neurologists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain specialists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: General population (age- and sex-matched)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neurologists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Headache specialists
Number of subjects: 0
Study: 30657531

Group type: EXPERIMENTAL
Intervention: Volar locking plate system (n=65)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Bridging external fixation (n=64)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Percutaneous pinning (n=58)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Casting (n=117)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: External fixation (n=64)
Number of subjects: 296
Study: 28711423

Group type: EXPERIMENTAL
Intervention: Sensor system intervention
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care (comparison group)
Number of subjects: 171
Study: 25809579

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment for 1 year
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (meta-analysis of eight trials)
Number of subjects: 104
Study: 23650431

Group type: EXPERIMENTAL
Intervention: 40 mg nebulized furosemide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 21869624

Group type: EXPERIMENTAL
Intervention: 40-m repeated sprint training (TG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study: 19595037

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) group (5 minutes of ischemia followed by 5 minutes of reperfusion)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (received Pringle's maneuver, no ischemic preconditioning)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (IP and Control)
Number of subjects: 48
Study: 17456554

Group type: EXPERIMENTAL
Intervention: Tap water irrigation
Number of subjects: 715

Group type: COMPARATOR
Intervention: Sterile saline irrigation
Number of subjects: 715
Study: 15521273

Group type: EXPERIMENTAL
Intervention: Advanced surface ablation (PASA) using Nidek EC-5000 laser
Number of subjects: 17
Study: 11558026

Group type: EXPERIMENTAL
Intervention: Ligation
Number of subjects: 13

Group type: COMPARATOR
Intervention: Vasoconstrictive treatment (vasopressin/terlipressin)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Vasoactive treatment (somatostatin/octreotide)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sclerotherapy
Number of subjects: 13
Study: 9761517

Group type: EXPERIMENTAL
Intervention: Felodipine (ER tablets, 10 mg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 7834862

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis (CF) platelets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal cells (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterozygote individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cystic fibrosis (CF) platelets and control platelets
Number of subjects: 0
Study: 3341541

Group type: EXPERIMENTAL
Intervention: Intragastric infusion of sodium hydroxide
Number of subjects: 166

Group type: COMPARATOR
Intervention: Intragastric infusion of saline solution or hydrochloric acid
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Negative test results
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Positive test results
Number of subjects: 166
Study: 31070072

Group type: EXPERIMENTAL
Intervention: Double-layer, far-far-near-near (FFNN) unlocked technique
Number of subjects: 138

Group type: COMPARATOR
Intervention: Single-layer continuous locked (SLL) technique
Number of subjects: 138
Study: 29753800

Group type: EXPERIMENTAL
Intervention: Sexual intercourse
Number of subjects: 12

Group type: COMPARATOR
Intervention: Abstinence from sexual intercourse
Number of subjects: 12
Study: 27391830

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning applied on the upper extremity for three cycles on postoperative days 1, 5, and 12.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 30
Study: 24861558

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Long term combinations of NRT
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: All pharmacotherapies
Number of subjects: 737
Study: 22867074

Group type: EXPERIMENTAL
Intervention: Kids Nutrition and Fitness program (6-week nutrition and physical activity educational after-school program)
Number of subjects: 251
Study: 20056003

Group type: EXPERIMENTAL
Intervention: Vitamin D3 40,000 IU per week (DD group)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Vitamin D3 20,000 IU per week (DP group)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo (PP group)
Number of subjects: 421
Study: 18684793

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17520505

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitors (AChE-I) including donepezil, galantamine, and rivastigmine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cholinesterase inhibitors (AChE-I)
Number of subjects: 100
Study: 14560174

Group type: EXPERIMENTAL
Intervention: QD (10 mg of Adderall at 7:30 a.m. and placebo at noon)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BID (10 mg of Adderall at 7:30 a.m. and at noon)
Number of subjects: 12
Study: 10881557

Group type: EXPERIMENTAL
Intervention: Nondeontic versions of the Wason selection task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deontic contexts
Number of subjects: 0
Study: 9101392

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 1323
Study: 8226444

Group type: EXPERIMENTAL
Intervention: Ambient [Hb] of 15.9 ± 0.7 g/100 ml breathing 21 or 12% O2
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Decreased [Hb] to 13.8 ± 0.6 g/100 ml by venesection and isovolemic replacement with 5% albumin in 0.9% saline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Decreased [Hb] to 13.8 ± 0.6 g/100 ml
Number of subjects: 7
Study: 3711026

Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Thiothixene
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Loxapine and Thiothixene
Number of subjects: 58
Study: 29101521

Group type: EXPERIMENTAL
Intervention: Transducer frequency set at 1.7/3.3 MHz
Number of subjects: 22

Group type: COMPARATOR
Intervention: Transducer frequency set at 1.5/3.0 MHz
Number of subjects: 22
Study: 26694209

Group type: EXPERIMENTAL
Intervention: Tranexemic acid (1 g) administered after induction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no tranexemic acid)
Number of subjects: 50
Study: 24036634

Group type: EXPERIMENTAL
Intervention: Direct-acting antivirals (DAAs) for 12 weeks with peg-interferon/ribavirin (peg-IFN/RBV) for 48 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo plus peg-interferon/ribavirin (peg-IFN/RBV)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: peg-interferon/ribavirin (peg-IFN/RBV) regimen
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HCV-PRO
Number of subjects: 74
Study: 22746973

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (PSL) plus the LTRA pranlukast (PRL) for 2 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Oral prednisolone (PSL) alone
Number of subjects: 23
Study: 20144246

Group type: EXPERIMENTAL
Intervention: L. plantarum MF1298 (10^10 CFU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 18716499

Group type: EXPERIMENTAL
Intervention: Chronic low back pain (CLBP) patients
Number of subjects: 103

Group type: COMPARATOR
Intervention: Pain-free individuals
Number of subjects: 103
Study: 15889583

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group treatment (CBGT) administered over 8, 90 min weekly sessions
Number of subjects: 19

Group type: COMPARATOR
Intervention: Delayed treatment (wait list)
Number of subjects: 19
Study: 15552855

Group type: EXPERIMENTAL
Intervention: Daily toothbrushing under supervision of trained teacher
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily toothbrushing under supervision of parents
Number of subjects: 0
Study: 10544378

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at an initial dose of 0.125 U/kg/week for the first month, then 0.25 U/kg/week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8688278

Group type: EXPERIMENTAL
Intervention: Crystalloid-hydroxyethylstarch combination (lactated Ringer's solution 1000 ml with up to 1000 ml of 6% hydroxyethylstarch)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Colloid without crystalloid (up to 1000 ml of 6% hydroxyethylstarch)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Crystalloid-gelatin combination (lactated Ringer's solution 1000 ml with up to 1000 ml of modified gelatin)
Number of subjects: 90
Study: 1852912

Group type: EXPERIMENTAL
Intervention: Various set-up methods for accuracy of field placement
Number of subjects: 20
Study: 6664154

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Naloxone (32 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg) + Naloxone (8 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg) + Naloxone (32 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31167726

Group type: EXPERIMENTAL
Intervention: CMA group
Number of subjects: 27
Study: 30103851

Group type: EXPERIMENTAL
Intervention: Intimate-partner violence (using the Composite Abuse Scale)
Number of subjects: 0
Study: 27243803

Group type: EXPERIMENTAL
Intervention: Nivolumab 0.3, 2, or 10 mg/kg intravenously every 3 weeks
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Nivolumab (treated beyond progression)
Number of subjects: 168
Study: 25455429

Group type: EXPERIMENTAL
Intervention: High task control (compared to neutral)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: High task control (compared to low)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Low task control
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Low task control effects
Number of subjects: 110

Group type: COMPARATOR
Intervention: Neutral task control
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: High task control
Number of subjects: 110
Study: 23034262

Group type: EXPERIMENTAL
Intervention: Alprostadil (prostaglandin E) administration during surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no alprostadil)
Number of subjects: 0
Study: 20452186

Group type: EXPERIMENTAL
Intervention: Bilateral sagittal split osteotomies (BSSO)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mandibular distraction osteogenesis (MDO)
Number of subjects: 23
Study: 18035291

Group type: EXPERIMENTAL
Intervention: Lumbar spine flexed (Group F)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lumbar spine in neutral position (Group N)
Number of subjects: 33
Study: 15111966

Group type: EXPERIMENTAL
Intervention: Rectal resection with lowest percent of purulent complications
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Differential approach to choice of resection or extirpation method
Number of subjects: 589
Study: 12460130

Group type: EXPERIMENTAL
Intervention: MET/CBT5 (6-week intervention with 2 sessions of individual motivational enhancement therapy plus 3 sessions of group cognitive behavioral therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MET/CBT12 (12-week intervention with 2 sessions of motivational enhancement therapy plus 10 sessions of group cognitive behavioral therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MET/CBT12 + FSN (12-week intervention with MET/CBT12 plus family support network)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACRA (12-week intervention based on adolescent community reinforcement approach)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDFT (multi-dimensional family therapy)
Number of subjects: 0
Study: 18314570

Group type: EXPERIMENTAL
Intervention: Exercise intervention, nutrition counseling, home safety assessment, smoking and alcohol interventions for at-risk subjects.
Number of subjects: 100
Study: 8612440

Group type: EXPERIMENTAL
Intervention: Chronic intermittent intravenous insulin therapy (CIIIT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control phase (no CIIIT)
Number of subjects: 26
Study: 2682969

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid combination (group A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Penicillin, aminoside, and metronidazole combination (group B)
Number of subjects: 82
Study: 4830231

Group type: EXPERIMENTAL
Intervention: Active ileal absorption of chenodeoxycholic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Active ileal absorption of glycochenodeoxycholic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Active ileal absorption of taurocholic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Passive permeability of the jejunum to bile acids
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of absorption rates
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Effect of intraluminal pH on jejunal uptake
Number of subjects: 12
Study: 31154601

Group type: EXPERIMENTAL
Intervention: Intervention group (implementation intentions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intervention plus booster group (implementation intentions + reminder)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 30124367

Group type: EXPERIMENTAL
Intervention: Collaborative intervention process (experimental group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 18
Study: 28549278

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 188
Study: 25546413

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF) diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intermittent fasting (IF) with anti-oxidant (vitamins C and E) supplementation
Number of subjects: 24
Study: 23182924

Group type: EXPERIMENTAL
Intervention: Maternal dietary counselling during pregnancy and breastfeeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children's dietary fatty acid intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no dietary counselling)
Number of subjects: 0
Study: 22696911

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both beta blockers (Carvedilol and Propranolol)
Number of subjects: 62
Study: 19046483

Group type: EXPERIMENTAL
Intervention: ADHD subjects off medication for 24 hours
Number of subjects: 52

Group type: COMPARATOR
Intervention: ADHD subjects on medication
Number of subjects: 52
Study: 17218764

Group type: EXPERIMENTAL
Intervention: ASA‐VitC (1.6 g ASA + 0.96 g Vit C/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: ASA (1.6 g ASA/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ASA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ASA and ASA‐VitC
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MKN‐45 cells incubated with ASA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MKN‐45 cells incubated with ASA‐VitC
Number of subjects: 10
Study: 10588398

Group type: EXPERIMENTAL
Intervention: Suprathreshold right unilateral or bilateral ECT
Number of subjects: 268
Study: 8720309

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium suppositories
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral administration of commercial enteric coated tablet
Number of subjects: 12
Study: 2010637

Group type: EXPERIMENTAL
Intervention: 566C80 3000 mg once daily for 12 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 566C80 750 mg three times daily for 5 days, then twice daily for 16 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 566C80 (various dosages: 100, 250, 750, 1500 mg)
Number of subjects: 20
Study: 7035299

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 g daily for three days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups (treatment and control)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Presence of encephalopathy, serum bilirubin > 340 micromol/l, serum creatinine > 250 micromol/l, histological evidence of cirrhosis
Number of subjects: 55
Study: 31954466

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 907

Group type: COMPARATOR
Intervention: Phacoemulsification cataract surgery (PCS)
Number of subjects: 907
Study: 30827132

Group type: EXPERIMENTAL
Intervention: BART - LVH
Number of subjects: 4714

Group type: EXPERIMENTAL
Intervention: Sokolow-Lyon - LVH
Number of subjects: 4714

Group type: EXPERIMENTAL
Intervention: Peguero-Lo Presti
Number of subjects: 4714

Group type: EXPERIMENTAL
Intervention: Cornell voltage product
Number of subjects: 4714

Group type: EXPERIMENTAL
Intervention: Cornell voltage
Number of subjects: 4714

Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance imaging - LVH
Number of subjects: 4714

Group type: COMPARATOR
Intervention: Traditional ECG - LVH criteria
Number of subjects: 4714
Study: 29415175

Group type: EXPERIMENTAL
Intervention: TDF/FTC
Number of subjects: 498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study: 27119940

Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham light therapy
Number of subjects: 28
Study: 24742364

Group type: EXPERIMENTAL
Intervention: Oral iodinated activated charcoal (IAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22728413

Group type: EXPERIMENTAL
Intervention: Caffeinated drink (CAF‐‐5 mg · kg(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 20670325

Group type: EXPERIMENTAL
Intervention: Full-immersion virtual reality (VR) training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standardized patient (SP) drill
Number of subjects: 15
Study: 17889344

Group type: EXPERIMENTAL
Intervention: Computer-based radiology simulator
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no simulator)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 12
Study: 16238677

Group type: EXPERIMENTAL
Intervention: Dalteparin 120 IU kg(‐1) s.c. twice daily for 5‐7 days followed by 5,000 or 7,500 IU twice daily for 3 months
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Dalteparin treatment
Number of subjects: 555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555
Study: 11889300

Group type: EXPERIMENTAL
Intervention: Thioglycolate transport medium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline transport medium
Number of subjects: 30
Study: 9440409

Group type: EXPERIMENTAL
Intervention: 2-week clerkship in physical medicine and rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-clerkship knowledge assessment
Number of subjects: 0
Study: 7879323

Group type: EXPERIMENTAL
Intervention: High energetic shock wave treatment (Lithotripter MFL 5000, 2000 impulses per session, 2 sessions, energy 18 kV‐22 kV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High energetic shock wave treatment
Number of subjects: 20